Clinical Trials on Prostate Cancer Metastatic Castration Resistant in United States
Total 5736 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
Hoffmann-La RocheCompleted
-
Duke UniversityCompleted
-
Accelerated Community Oncology Research NetworkBayerTerminatedMetastatic Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Carcinoma Metastatic in the BoneUnited States
-
Astellas Pharma IncTerminatedCastrate Resistant Prostate CancerBelgium, France, United Kingdom
-
University of UtahCompletedMetastatic Prostate Carcinoma | Stage IV Prostate Cancer | Prostate Carcinoma Metastatic in the BoneUnited States
-
BayerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Jonsson Comprehensive Cancer CenterTerminatedBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Thomas Jefferson UniversityNot yet recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Peng Wang, MD PhDWithdrawnMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Dana-Farber Cancer InstituteProstate Cancer FoundationRecruitingPROSTATE CANCER | Metastatic Prostate Cancer | Metastatic Prostate CarcinomaUnited States
-
Washington University School of MedicineBristol-Myers Squibb; The Foundation for Barnes-Jewish Hospital; Bavarian Nordic and other collaboratorsCompletedMetastatic Hormone-Sensitive Prostate CancerUnited States
-
University of ChicagoRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer MetastaticUnited States
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
SanofiCompleted
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Memorial Sloan Kettering Cancer CenterUniversity of North Carolina; New York-Presbyterian Hospital Cornell Medical...CompletedPain | Metastatic Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
Dana MathewsNo longer availableProstate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Mamta ParikhNational Cancer Institute (NCI); PandomedxCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedUrothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral... and other conditionsUnited States
-
David VanderWeeleTerminatedCastrate Resistant Prostate CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI); Prostate Cancer FoundationRecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Carolina Research Professionals, LLCBayerUnknownProstate Cancer MetastaticUnited States
-
Janssen Research & Development, LLCCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Phoenix Molecular ImagingCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
US Oncology ResearchPfizerCompleted
-
Case Comprehensive Cancer CenterRecruitingMetastatic Prostate CancerUnited States
-
Martha MimsRecruitingProstate Cancer | Prostate Cancer MetastaticUnited States
-
University of Alabama at BirminghamCompletedMetastatic Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedMetastatic Prostate CancerUnited States
-
University of MichiganCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
University of Colorado, DenverCompletedBone Metastases | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Soft Tissue MetastasesUnited States
-
Mayo ClinicNot yet recruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
SanofiTerminated
-
Tulane UniversityNo longer availableProstatic Neoplasms | Prostatic Neoplasms, Castration-ResistantUnited States
-
CellCentric Ltd.RecruitingAdvanced Solid Tumors | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Metastatic Castration-Resistant Prostate CancerUnited Kingdom, United States, Netherlands, France, Spain, Sweden
-
Power Life Sciences Inc.Not yet recruitingMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingSolid Tumor | Prostate Cancer | Advanced Solid Tumor | Metastatic Prostate Cancer | Prostate NeoplasmUnited States